• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Guide (MA30

  2026-08-04

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific and reproducible detection of HMGB1 protein in human, mouse, and rat research samples using Western blot, immunohistochemistry, and flow cytometry. It is not validated for diagnostic, therapeutic, or medical applications and is best suited for chromatin-associated protein studies within controlled research environments.

• Artesunate as an Artemisinin Derivative in Cancer Workflows

  2026-08-04

  Artesunate is redefining in vitro cancer research as a high-purity artemisinin derivative, enabling robust cell death and proliferation assays. Its dual action as a ferroptosis inducer and AKT/mTOR pathway inhibitor streamlines experimental workflows, particularly in challenging small cell lung and esophageal squamous cell carcinoma models.

• Z-DEVD-FMK (SKU A1920): Reliable Caspase-3 Inhibitor for Apo

  2026-08-03

  This article offers an evidence-based, scenario-driven exploration of Z-DEVD-FMK (SKU A1920) for apoptosis and neuroprotection research. By addressing real laboratory challenges, it illustrates how Z-DEVD-FMK's validated protocol parameters, broad caspase inhibition, and reproducibility—supported by APExBIO—enhance reliability in cell viability and cytotoxicity workflows.

• SAR131675: Advanced VEGFR-3 Inhibitor Workflows & Troublesho

  2026-08-03

  SAR131675 unlocks precision targeting of VEGFR-3 in lymphangiogenesis, angiogenesis, and tumor models. This guide delivers actionable protocols, troubleshooting wisdom, and translational insights—driven by new evidence and APExBIO's trusted reliability.

• miR-1268a Controls CD36-Mediated Fatty Acid Metabolism in An

  2026-08-02

  This study uncovers a novel role for miR-1268a in regulating fatty acid metabolism through direct targeting of CD36 in human cardiomyocytes subjected to Angiotensin II-induced stress. The findings provide mechanistic insight into the metabolic remodeling characteristic of heart failure and highlight miR-1268a as a potential therapeutic target for metabolic intervention in cardiovascular disease.

• HAUS1 Expression and Immune Microenvironment in HCC Prognosi

  2026-08-01

  This study explores the prognostic value of HAUS1 expression in hepatocellular carcinoma (HCC) and its association with the tumor immune microenvironment. The findings highlight HAUS1 as a potential biomarker and therapeutic target, with implications for prognosis and immunotherapeutic strategy in HCC.

• Technical Use of Angiotensin I/II (1-5) in RAS Research Work

  2026-07-31

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled modeling of the renin-angiotensin system, specifically in studies of blood pressure regulation and aldosterone signaling. It is not suitable for research outside cardiovascular and renal signaling due to its mechanistic and solubility profile.

• Polyethylenimine Linear (PEI) MW 40,000: Optimizing DNA Tran

  2026-07-31

  Polyethylenimine Linear (PEI), MW 40,000, stands out as a versatile DNA transfection reagent for in vitro studies, delivering robust and reproducible gene expression across a spectrum of cell lines and scales. This article details best-practice protocols, advanced use-cases, and troubleshooting strategies to help researchers maximize transfection efficiency and experimental throughput.

• SAR131675: Illuminating VEGFR-3 Inhibitor Utility in Hepatic

  2026-07-30

  Explore how SAR131675, a selective VEGFR-3 inhibitor, enables precise dissection of the VEGFC–VEGFR-3 axis in hepatic fibrosis and immune modulation. This analysis offers fresh insights distinct from standard angiogenesis workflows, guiding advanced research applications.

• RP3-340N1.2 Knockdown Limits NSCLC Growth via IL-6 mRNA Dest

  2026-07-30

  The reference study reveals that the lncRNA RP3-340N1.2 promotes non-small cell lung cancer (NSCLC) proliferation and migration by stabilizing IL-6 mRNA. Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation through increased interaction with ZC3H12A, suggesting a novel therapeutic avenue for disrupting tumor-promoting cytokine signaling in NSCLC.

• Synthetic mRNA-Induced DEFB1 Reduces Cryptosporidium Infecti

  2026-07-29

  This study demonstrates that transfection of human intestinal cells with synthetic DEFB1 mRNA markedly increases β-defensin 1 protein production, resulting in a substantial (~80%) reduction in Cryptosporidium parvum infection. The findings support mRNA-based host-directed therapy as a promising platform for combating enteric parasites, with implications for rapid functional genomics and therapeutic development.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-07-29

  This study introduces a streamlined 13-step synthesis of deuterium-labeled degarelix acetate, a crucial internal standard for pharmacokinetic studies of GnRH antagonists like degarelix. The method leverages D2O/D3PO4 as a deuterium source and provides a reproducible route for stable isotope labeling, enhancing clinical metabolism research and drug development.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-07-28

  Dimethyloxalylglycine (DMOG) enables controlled stabilization of hypoxia-inducible factors in cell and animal models, supporting research in oxygen sensing, hypoxia signaling, and inflammatory pathway modulation. It is not intended for diagnostic or clinical applications, and strict adherence to solubility, storage, and protocol recommendations is essential for reproducible results.

• Safe DNA Gel Stain: Advancing Nucleic Acid Detection and Bio

  2026-07-28

  This thought-leadership article explores the mechanistic and strategic advantages of Safe DNA Gel Stain for translational researchers. It integrates insights from recent wheat genomics research, discusses the limitations of traditional nucleic acid stains, and provides actionable guidance for maximizing experimental integrity and biosafety. The article also contextualizes APExBIO’s Safe DNA Gel Stain within next-generation workflows, setting a new benchmark for safe, sensitive, and reproducible DNA and RNA detection.

• Site-Specific PEGylation of IL-11 Attenuates Pulmonary Fibro

  2026-07-27

  This study pioneers a receptor-biased strategy by site-specific PEGylation of interleukin-11 at the GP130 interface, effectively reducing bleomycin-induced pulmonary fibrosis in mice. The approach offers a selective means of modulating IL-11 signaling, highlighting both mechanistic insights and translational potential for future antifibrotic therapies.

15876 records 1/1059 page Next 12345 下5页 Last page